Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sucrose octasulfate (sodium)

Sucrose octasulfate sodium, a derivative of sulfated oligosaccharides, is a matrix metalloproteinase (MMP) inhibitor. Sucrose octasulfate sodium stimulates the release of somatostatin-like immunoreactivity (SLI) from the stomach by acting directly on D cells in the gastric mucosa. Sucrose octasulfate sodium exerts its ulcer-healing effect by releasing endogenous gastric somatostatin. Sucrose octasulfate sodium can be used as a pharmaceutical excipient and significantly improves wound closure in diabetic foot ulcers caused by nerve ischemia and venous leg ulcers. Sucrose octasulfate sodium can be used in the study of chronic wound healing[1][2][3].

Product Specifications

CAS Number

[74135-10-7]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

MMP; Somatostatin Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sucrose-octasulfate-sodium.html

Purity

98.0

Solubility

H2O : 116.67 mg/mL (ultrasonic)

Smiles

O=[S](OC[C@]([C@H]([C@@H]1O[S](=O)(O[Na])=O)O[S](=O)(O[Na])=O)(O[C@@H]1CO[S](=O)(O[Na])=O)O[C@@H](O[C@@H]2CO[S](=O)(O[Na])=O)[C@@H]([C@H]([C@@H]2O[S](=O)(O[Na])=O)O[S](=O)(O[Na])=O)O[S](=O)(O[Na])=O)(O[Na])=O

Molecular Formula

C12H14Na8O35S8

Molecular Weight

1158.66

Precautions

H302, H315, H319, H335

References & Citations

[1]Lucey MR, et al. Sucrose octasulfate stimulates gastric somatostatin release. Am J Med. 1991 Aug 8;91 (2A) :52S-57S.|[2]Edmonds M, et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer) : an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6 (3) :186-196.|[3]Dissemond J, et al. Sucrose Octasulfat – Evidenz in der Behandlung chronischer Wunden [Sucrose octasulfate-evidence in the treatment of chronic wounds]. Hautarzt. 2020 Oct;71 (10) :791-801. German.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Pinus contorta Photosystem Q (B) protein, partial
MBS7058382 Inquire

Recombinant Pinus contorta Photosystem Q (B) protein, partial

Sign In for Pricing
View Details
Actl6a (Actin-like Protein 6A, 53kD BRG1-Associated Factor A, Actin-Related Protein Baf53a, BRG1-Associated Factor 53A, BAF53A, Actl6a, Actl6, Baf53a)
302242 200 µL

Actl6a (Actin-like Protein 6A, 53kD BRG1-Associated Factor A, Actin-Related Protein Baf53a, BRG1-Associated Factor 53A, BAF53A, Actl6a, Actl6, Baf53a)

Sign In for Pricing
View Details
Frozen Tissue Sections, Skin
CS638001 5x 5 µm

Frozen Tissue Sections, Skin

Sign In for Pricing
View Details
Dtd1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K6105406 1.0 µg DNA

Dtd1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

Sign In for Pricing
View Details
Kylt® Francisella orientalis
31572 25 Reactions

Kylt® Francisella orientalis

Sign In for Pricing
View Details
CDK1/2/4-IN-2
MF-0114237-01 10 mg

CDK1/2/4-IN-2

Sign In for Pricing
View Details